spiperone has been researched along with Cardiac Hypertrophy in 1 studies
Spiperone: A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.
spiperone : An azaspiro compound that is 1,3,8-triazaspiro[4.5]decane which is substituted at positions 1, 4, and 8 by phenyl, oxo, and 4-(p-fluorophenyl)-4-oxobutyl groups, respectively.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The characteristics of dopamine receptors were studied in heart and kidney using the radiolabeled receptor assay of [3H]spiperone during the development of cardiac hypertrophy." | 3.68 | Altered renal dopamine receptors during development of cardiac hypertrophy. ( Chen, Y; Ganguly, PK; Mukherjee, K, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganguly, PK | 1 |
| Mukherjee, K | 1 |
| Chen, Y | 1 |
1 other study available for spiperone and Cardiac Hypertrophy
| Article | Year |
|---|---|
Altered renal dopamine receptors during development of cardiac hypertrophy.
Topics: Animals; Aorta, Abdominal; Body Weight; Cardiomegaly; Constriction, Pathologic; Kidney; Kidney Corte | 1992 |